查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1212611

荷尔蒙补充疗法(HRT)的全球市场 2023

Hormone Replacement Therapy (HRT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

荷尔蒙补充疗法(HRT)的全球市场到2030年将达到401亿美元

在COVID-19后改变的商务环境中，2022年245亿美元的荷尔蒙补充疗法(HRT)的全球市场，是2030年之前达到401亿美元的规模，在分析期间2022年～2030年间预计将以6.3％的年复合成长率成长。本报告所分析的市场区隔之一的雌激素荷尔蒙置换疗法，年复合成长率将记录6.4％，到分析期间结束时达到219亿美元。考虑疫情后的復苏，人体生长荷尔蒙补充疗法领域今后8年的年复合成长率将修正为7.5％。

美国市场估算为72亿美元，中国则将以年复合成长率5.9％的速度成长

美国的荷尔蒙补充疗法(HRT)市场在2022年估算为72亿美元。作为世界第2大经济大国的中国，在2022年～2030年间年复合成长率预计将为5.9％，2030年达到70亿美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年间预计将各以5.7％和5.2％的速度成长。在欧洲市场中，德国将以年复合成长率约4.8％成长。

调查对像企业范例

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-6453

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Hormone Replacement Therapy (HRT) Market to Reach $40.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Hormone Replacement Therapy (HRT) estimated at US$24.5 Billion in the year 2022, is projected to reach a revised size of US$40.1 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2022-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$21.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 5.9% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 47 Featured):

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • An Introduction to Menopause and Hormone Replacement Therapy
    • Recent Market Activity
    • The HRT Controversy - An Insight
    • Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
    • Revised Recommendations of the NAMS and Endocrine Society
    • IMS Consensus Guidelines Paving Way for More Clarity of HRT
    • The Regional Divide
    • Increasing Number of Menopausal Women - A Major Market Driver
    • New Bioidentical Drugs Serve Unmet Market Needs
    • Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
    • Intense Competition Marks the Global HRT Market
    • The Premarin Saga
    • Estrace Cream Drives Revenue Gains in Allergan's HRT Portfolio
    • Hormone Replacement Therapy (HRT) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • Allergan Plc (Ireland)
    • Bayer AG (Germany)
    • Noven Pharmaceuticals, Inc. (USA)
    • Novartis AG(Switzerland)
    • Novo Nordisk A/S (Denmark)
    • Orion Pharma AB (Finland)
    • Pfizer, Inc. (USA)
    • TherapeuticsMD, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
    • Topical Estrogens - More Safe and Effective
    • Transdermal HRT Products Present Exciting Opportunities
    • Phytoestrogens - The New Panacea for Menopausal Symptoms?
    • Diet Link to Menopause Symptoms Raises Interest
    • Impact of Soy and Other Phytoestrogens - A Reality Check
    • EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
    • The Growing Buzz around Bioidentical Drugs
    • Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
    • Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT
    • Direct-to-Consumer Advertising for HRT - A Mixed Bag
    • Estriol: The Next Generation Estrogen Therapy?
    • What Makes Estriol Work?
    • Topical Estriol - More Promising in Safety
    • Estriol - Used More Commonly Outside the US
    • Entry of Generics Threatens Market Growth Prospects
    • Are Non-Hormonal Therapies A Threat to HRT?
    • Earlier Failures Induce Lethargy in Non-Hormonal Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Estrogen Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Human Growth Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Testosterone Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Thyroid Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Male Hypogonadism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Growth Hormone Deficiency by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 27: World 18-Year Perspective for Hypothyroidism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 30: World 18-Year Perspective for Other Type of Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 31: World Hormone Replacement Therapy (HRT) Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: USA 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: USA 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Canada 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • JAPAN
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • CHINA
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: China 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: China 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • EUROPE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • FRANCE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: France 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: France 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • GERMANY
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Germany 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Germany 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Italy 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Italy 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: UK 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: UK 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Rest of World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Rest of World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030

IV. COMPETITION